IDEX Corporation (IEX) Q2 2026 Filing Summary
Business Context and Reporting Period
This summary covers IDEX Corporation's Form 10-Q for the quarterly period ended June 30, 2026. IDEX is an applied solutions provider specializing in Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The company operates globally, with significant exposure to industrial activity levels, currency fluctuations, and trade policies.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Net Sales | $920.6M | $865.4M | $1,807.5M | $1,679.7M |
| Gross Profit | $426.8M | $392.2M | $824.9M | $761.1M |
| Gross Margin | 46.3% | 45.3% | 45.6% | 45.3% |
| Operating Income | $199.9M | $187.9M | $372.3M | $329.9M |
| Net Income (Attributable to IDEX) | $143.4M | $131.6M | $263.4M | $227.1M |
| Diluted EPS | $1.93 | $1.74 | $3.54 | $3.00 |
| Adjusted EBITDA | $258.3M | $237.2M | $488.7M | $445.2M |
| Operating Cash Flow (YTD) | $303.7M (vs $267.4M YTD 2025) | |||
| Free Cash Flow (YTD) | $263.0M (vs $238.3M YTD 2025) | |||
| Total Debt (Long-term + Current) | $1,858.9M (as of June 30, 2026) | |||
| Cash & Equivalents | $621.3M (as of June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6% in Q2 and 8% YTD, driven by 5% organic growth. The HST segment was the primary driver, benefiting from AI-driven demand in data centers and semiconductors.
- Tariff Refunds (IEEPA): A U.S. Supreme Court ruling invalidated broad-based tariffs. IDEX collected refunds resulting in a $22.0M reduction in Cost of Sales and a $14.7M reduction in Net Sales (due to customer rebates). The net benefit contributed $0.08 to Q2 EPS.
- Margin Expansion: Gross margin improved by 100 basis points in Q2 and 30 basis points YTD, aided by volume leverage, productivity, and the net benefit of tariff refunds.
- Restructuring & Impairments: Expenses totaled $2.8M in Q2 and $10.2M YTD. The YTD figure includes $4.8M in asset impairments (intangible assets and PP&E) within the FMT segment.
- Share Repurchases: The company repurchased 0.7M shares for $151.3M YTD. As of June 30, 2026, $774.7M of authorization remained.
Guidance, Outlook, and Risks
- Outlook: Management expects continued strength in targeted advantaged markets (data centers, semiconductors, space/defense). The company anticipates that current cash, operating cash flow, and revolver availability ($529.6M) are sufficient for foreseeable needs.
- Tariff Environment: While IEEPA tariffs were invalidated, the administration has implemented new tariffs under alternative authority. Management monitors these for potential impacts on pricing and costs.
- Legal Contingencies: The company is involved in asbestos-related litigation (claims covered largely by insurance) and other routine legal proceedings. No material adverse effect is currently anticipated.
- Acquisitions: The Micro-LAM acquisition (July 2025) is contributing to the HST segment. An earnout of up to $12.0M is contingent on future performance.
Investor Verification Checklist
- IEEPA Tariff Impact: Verify the sustainability of the $22.0M cost reduction and the extent of customer rebates ($14.7M) impacting reported revenue.
- HST Segment Growth: Assess the durability of volume growth in AI/data center and semiconductor markets driving the HST segment.
- FMT Segment Impairments: Review the $4.8M impairment charge in the FMT segment to understand if it signals broader asset underperformance.
- Working Capital Trends: Monitor the $58.0M increase in operating working capital YTD, driven by higher receivables and inventories.
- Debt Covenants: Confirm continued compliance with leverage (1.87x) and interest coverage (14.17x) ratios under the Revolving Facility.